Infant acute leukemia and maternal exposures during pregnancy

Cancer Epidemiology Biomarkers and Prevention

Volumn 15, Issue 12, 2006, Pages 2336-2341

  Pombo De Oliveira, Maria S ^a   Koifman, Sergio ^b   Araújo, Paulo Ivo C ^c   Alencar, Dora Mârcia ^d   Brandalise, Silvia R ^e   Guimarães Carvalho, Eni ^f   Coser, Virginia M ^g   Costa, Imaruí ^g   Córdoba, José Carlos ^h   Emerenciano, Mariana ^a   Dobbin J, Jane ^a   Moraes Guerra, Maria Célia ^c   Gumes Lopes, Venâncio ^d   Magalhães, Isis Q ^h   Mendonça, Núbia ^d   Gadelha, Andrea ⁱ   Guedes, Gilson ⁱ   Pimenta, Flávia ⁱ   Pinheiro, Vitória P ^e   Pereira, Waldir ^g   Ramos, Gilberto ^j   Salles, Terezinha J M ^k   Bousfield Da Silva, Denise ^l   Land, Marcelo P ^c   Sobral, Elaine ^c   Werneck, Fernando ^m   Scridelli, Carlos ⁿ   Gonzaga Tone, Luis ⁿ   Vermondi, Lincoln ^l   Lopes, Luis Fernando ^o   Mendes, Wellinghton ^o   more..

^a INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^d Sociedade de Oncologia da Bahia   (Brazil)

^e Centro Infantil Dr Domingos A Boldrini   (Brazil)

^f Hosp Martagao Gesteira   (Brazil)

^g Universidade de Santa Maria   (Brazil)

^h Hospital Universitario de Brasilia   (Brazil)

ⁱ Hosp Cancer Napoleao Laureano   (Brazil)

^j FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^k Hospital Oswaldo Cruz   (Brazil)

^l HOSPITAL INFANTIL JOANA DE GUSMÃO   (Brazil)

^m HOSPITAL DOS SERVIDORES DO ESTADO   (Brazil)

ⁿ UNIVERSITY OF SÃO PAULO   (Brazil)

^o A C CAMARGO CANCER CENTER   (Brazil)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ABORTIVE AGENT; ACETYLSALICYLIC ACID; AMOXICILLIN; ANTIEMETIC AGENT; CANNABIS; CIPROFLOXACIN; CODEINE; DIPYRONE; ESTROGEN; FOLIC ACID; HERBACEOUS AGENT; IRON; METRONIDAZOLE; MISOPROSTOL; MIXED LINEAGE LEUKEMIA PROTEIN; ORAL CONTRACEPTIVE AGENT; PARACETAMOL; PESTICIDE; PROGESTERONE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SCOPOLAMINE; THYROID HORMONE;

ACUTE LEUKEMIA; ADOLESCENT; ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BRAZIL; CANCER RISK; CARCINOGENESIS; CASE CONTROL STUDY; CHILD; CHILDHOOD ACUTE LEUKEMIA; CHILDHOOD LEUKEMIA; CHROMOSOME 11Q; CONTROLLED STUDY; DEMOGRAPHY; DRUG USE; ENVIRONMENTAL EXPOSURE; FEMALE; GENE REARRANGEMENT; GENE TRANSLOCATION; GENETIC ANALYSIS; GEOGRAPHIC DISTRIBUTION; HORMONAL THERAPY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRENATAL EXPOSURE; PRIORITY JOURNAL; SIDE EFFECT; SMOKING; VITAMIN SUPPLEMENTATION;

ACUTE DISEASE; BRAZIL; CASE-CONTROL STUDIES; FEMALE; HOSPITALS; HUMANS; INFANT; INFANT, NEWBORN; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOID; MALE; MATERNAL EXPOSURE; MATERNAL-FETAL EXCHANGE; MYELOID-LYMPHOID LEUKEMIA PROTEIN; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; TRANSLOCATION, GENETIC;

EID: 33846028181     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-06-0031     Document Type: Article

References (28)

1. Ford AM, Ridge SA, Cabrera ME, et al. In utero rearrangements in the trithorax-related oncogene in infant leukaemias. Nature 1993;363:358-60.
2. Greaves MF, Wiemels J. Origins of chromosome translocations in childhood leukaemia. Nat Rev Cancer 2003;3:639-49.
3. Greaves MF. Aetiology of acute leukaemia. Lancet 1997;349:344-9.
4. Gale KB, Ford AM, Repp R, et al. Backtracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots. Proc Natl Acad Sci U S A 1997;94:13950-4.
5. Biondi A, Cimino G, Pieters R, Pui CH. Biological and therapeutic aspects of infant leukemia. Blood 2000;96:24-33.
6. Isaacs H Jr. Fetal and neonatal leukemia. J Pediatr Hematol Oncol 2003;25:348-61.
7. Isoyama K, Okawa H, Hayashi Y, et al. Clinical and biological aspects of acute lymphoblastic leukemia in 62 infants: retrospective analysis of the Tokyo Children's Cancer Study Group. Pediatr Int 1999;41:477-83.
8. Ross JA, Potter JD, Robison LL. Infant leukemia, topoisomerase II inhibitors, and the MLL gene. J Natl Cancer Inst 1994;86:1678-80.
9. Strick R, Strissel PL, Borgers S, Smith SL, Rowley JD. Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia. Proc Natl Acad Sci U S A 2000;97:4790-5.
10. Ross JA, Potter JD, Reaman GH, Pendergrass TW, Robison LL. Maternal exposure to potential inhibitors of DNA topoisomerase II and infant leukemia (United States): a report from the Children's Cancer Group. Cancer Causes Control 1996;7:581-90.
11. Alexander FE, Patheal SL, Biondi A, et al. Transplacental chemical exposure and risk of infant leukemia with MLL gene fusion. Cancer Res 2001;61:2542-6.
12. Barletta E, Gorini G, Vineis P, et al. Ras gene mutations in patients with acute leukaemia and exposure to chemical agents. Carcinogenesis 2004;25:749-75.
13. Khoury MJ, Flanders WD. Nontraditional epidemiologic approaches in the
14. analysis of gene-environment interaction: case-control studies with no controls. Am J Epidemiol 1996;144:207-13.
15. Bain BJ. Leukemia diagnosis. London: Blackwell Science; 1997.
16. Emerenciano M, Agudelo Arias DP, Coser VM, et al. Molecular cytogenetic findings of acute leukemia included in the Brazilian Collaborative Study Group of Infant acute leukemia. Pediatr Blood Cancer 2006;47:549-54.
17. Parra FC, Amado RC, Lambertucci JR, et al. Color and genomic ancestry in Brazilians. Proc Natl Acad Sci U S A 2003;100:177-82.
18. Spector LG, Xie Y, Robison LL, et al. Maternal diet and infant leukemia: the DNA topoisomerase II inhibitor hypothesis: a report from the children's oncology group. Cancer Epidemiol Biomarkers Prev 2005;14:651-5.
19. Ross JA, Potter JD, Shu XO, et al. Evaluating the relationships among maternal reproductive history, birth characteristics, and infant leukemia: a report from the Children's Cancer Group. Ann Epidemiol 1997;7:172-9.
20. Alexander FE, Cartwright RA, McKinney PA, Ricketts TJ. Leukaemia incidence, social class, and estuaries: an ecological analysis. J Public Health Med 1990;12:109-17.
21. Ma X, Buffler PA, Gunier RB, et al. Critical windows of exposure to household pesticides and risk of childhood leukemia. Environ Health Perspect 2002;110:955-60.
22. Sharpe CR, Franco EL.; Brazilian Wilms' Tumor Study Group. Use of dipyrone during pregnancy and risk of Wilms' tumor. Epidemiology 1996;7:533-5.
23. Bromberg KD, Burgin AB, Osheroff N. A two-drug model for etoposide action against human topoisomerase IIα. J Biol Chem 2003;278:7406-12.
24. Baik I, Devito WJ, Ballen K, et al. Association of fetal hormone levels with stem cell potential: evidence for early life roots of human cancer. Cancer Res 2005;65:358-63.
25. Cavalieri EL, Stack DE, Devanesan PD, et al. Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators. Proc Natl Acad Sci U S A 1997;94:10937-42.
26. Cavalieri EL, Li KM, Balu N, et al. Catechol ortho-quinones: the electrophilic compounds that form depurinating DNA adducts and could initiate cancer and other diseases. Carcinogenesis 2002;23:1071-7.
27. Fasching K, Panzer S, Haas OA, et al. Presence of N regions in the clonotypic DJ rearrangements of the immunoglobulin heavy-chain genes indicates an exquisitely short latency in t(4;11)-positive infant acute lymphoblastic leukemia. Blood 2001;98:2272-4.
28. Garcia-Closas M, Thompson DW, Robins JM. Differential misclassification and the assessment of gene-environment interactions in case-control studies. Am J Epidemiol 1998;147:426-33.